TransMedics (TMDX) Operating Income Growth (1y) (2019 - 2026)
TransMedics (TMDX) Operating Income Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 74.18% |
| 10 | TransMedics | 2.51 Bn | 2.05 Bn | 101.16 Mn | -51.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.55% |
| Dec 31, 2025 | 146.10% |
| Sep 30, 2025 | 493.93% |
| Jun 30, 2025 | 192.35% |
| Mar 31, 2025 | 120.94% |
| Dec 31, 2024 | 232.08% |
| Sep 30, 2024 | 113.85% |
| Jun 30, 2024 | 1,480.57% |
| Mar 31, 2024 | 694.59% |
| Dec 31, 2023 | 138.40% |
| Sep 30, 2023 | -411.09% |
| Jun 30, 2023 | 90.70% |
| Mar 31, 2023 | 77.70% |
| Dec 31, 2022 | 40.16% |
| Sep 30, 2022 | 52.72% |
| Jun 30, 2022 | 1.25% |
| Mar 31, 2022 | -43.98% |
| Dec 31, 2021 | -92.13% |
| Sep 30, 2021 | -154.34% |
| Jun 30, 2021 | -25.53% |